1.
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients
by Vandemeulebroucke, E
Diabetologia, 2009, Vol.53 (1), p.36-44
2.
Beta cells in type 1 diabetes: mass and function; sleeping or dead?
by Oram, Richard A
Diabetologia, 2019, Vol.62 (4), p.567-577
3.
Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome
by Lindén Hirschberg, A
Gynecological endocrinology, 2004, Vol.19 (2), p.79-87
4.
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
by Hope, Suzy V
Diabetologia, 2017, Vol.61 (1), p.66-74
5.
Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function
by Merovci, Aurora
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (5), p.1927-1932
6.
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes
by WEETS, I
Diabetologia, 2006, Vol.49 (6), p.1158-1162
7.
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
by Perdigoto, Ana Luisa
Diabetologia, 2018, Vol.62 (4), p.655-664
8.
Abnormal ghrelin secretion in new onset childhood Type 1 diabetes
by Holdstock, C
Diabetologia, 2004, Vol.47 (1), p.150-151
9.
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
by Ma, Jing, PhD
The lancet oncology, 2008, Vol.9 (11), p.1039-1047
10.
Maternal Exposure to Bisphenol-A During Pregnancy Increases Pancreatic β-Cell Growth During Early Life in Male Mice Offspring
by García-Arévalo, Marta
Endocrinology (Philadelphia), 2016, Vol.157 (11), p.4158-4171
11.
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
by Espes, Daniel
Diabetologia, 2013, Vol.57 (1), p.50-53
12.
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
by Leslie, R. David
Diabetologia, 2015, Vol.59 (1), p.13-20
13.
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial
by Kramer, Caroline K
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (10), p.3702-3709
14.
Pancreatic Volume Is Reduced in Adult Patients with Recently Diagnosed Type 1 Diabetes
by Williams, Alistair J. K
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (11), p.E2109-E2113
15.
Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient
by Jacobs-Tulleneers-Thevissen, D
Diabetologia, 2013, Vol.56 (7), p.1605-1614
16.
Effects of Interrupting Children's Sedentary Behaviors With Activity on Metabolic Function: A Randomized Trial
by Belcher, Britni R
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (10), p.3735-3743
17.
18.
Continuous Glucose Monitoring after Islet Transplantation in Type 1 Diabetes: An Excellent Graft Function (β-Score Greater Than 7) Is Required to Abrogate Hyperglycemia, Whereas a...
by Vantyghem, Marie-Christine
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (11), p.E2078-E2083
19.
Incretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in Humans
by Lindgren, Ola
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (8), p.2519-2524
20.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
by Sherry, Nicole, Dr
The Lancet (British edition), 2011, Vol.378 (9790), p.487-497
